A recent work from the same group describes liposomes functionalized with 2C5, a mAb against cancer overexpressed nucleolin, for the codelivery of paclitaxel and salinomycin (to target both bulk cancer cells and cancer stem cells). Here, NUCLEOLIN is linked to cancer.